Lna Santé S.A. | Mid-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2018

Income Metrics

EPS (Diluted) €0.00

Balance Sheet Metrics

Total Assets 1.5B
Total Liabilities 1.2B
Shareholders Equity 323.6M
Debt to Equity 3.75

Cash Flow Metrics

Revenue & Profitability Trend

Lna Santé S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i806.6M736.1M728.2M689.5M573.9M
Cost of Goods Sold i85.1M76.7M105.8M111.6M92.9M
Gross Profit i721.5M659.4M622.4M577.9M481.0M
Gross Margin % i89.5%89.6%85.5%83.8%83.8%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i98.1M90.2M86.9M81.7M66.7M
Other Operating Expenses i44.3M43.9M41.2M44.0M30.6M
Total Operating Expenses i142.4M134.1M128.1M125.7M97.3M
Operating Income i67.3M63.3M64.2M58.9M47.1M
Operating Margin % i8.3%8.6%8.8%8.5%8.2%
Non-Operating Items
Interest Income i1.6M1.2M364.0K1.7M267.0K
Interest Expense i29.4M27.3M21.1M20.0M19.9M
Other Non-Operating Income-----
Pre-tax Income i34.1M37.3M43.2M36.3M18.6M
Income Tax i11.0M13.0M15.9M14.6M10.2M
Effective Tax Rate % i32.3%34.9%36.9%40.2%54.7%
Net Income i22.9M24.2M28.3M24.0M8.4M
Net Margin % i2.8%3.3%3.9%3.5%1.5%
Key Metrics
EBITDA i152.4M144.7M155.5M139.1M117.8M
EPS (Basic) i€2.13€2.29€2.49€2.45€0.81
EPS (Diluted) i€2.13€2.29€2.49€2.45€0.81
Basic Shares Outstanding i10225000102220001035900095790009582000
Diluted Shares Outstanding i10225000102220001035900095790009582000

Income Statement Trend

Lna Santé S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i75.1M77.2M102.0M151.8M121.0M
Short-term Investments i47.0K415.0K-348.0K353.0K
Accounts Receivable i76.3M56.1M69.5M66.5M44.8M
Inventory i179.0M148.3M98.4M85.7M86.4M
Other Current Assets-2.0K45.4M47.5M-764.0K
Total Current Assets i374.1M333.7M318.7M354.5M306.0M
Non-Current Assets
Property, Plant & Equipment i167.0M155.4M146.5M133.6M158.8M
Goodwill i715.9M701.3M702.5M682.8M672.7M
Intangible Assets i441.1M422.6M423.3M410.5M404.1M
Long-term Investments895.0K1.8M4.3M272.0K81.0K
Other Non-Current Assets-2.0K-1.0K2.0K1.0K-3.0K
Total Non-Current Assets i1.2B1.2B1.2B1.2B1.2B
Total Assets i1.5B1.5B1.5B1.5B1.5B
Liabilities
Current Liabilities
Accounts Payable i76.5M64.9M63.2M62.4M56.1M
Short-term Debt i179.7M144.7M295.4M344.0M330.8M
Current Portion of Long-term Debt-----
Other Current Liabilities110.4M101.6M89.8M84.4M131.9M
Total Current Liabilities i412.3M354.0M496.5M549.0M561.9M
Non-Current Liabilities
Long-term Debt i695.5M742.0M616.1M660.6M640.7M
Deferred Tax Liabilities i83.5M82.0M83.3M76.9M76.9M
Other Non-Current Liabilities10.9M9.3M9.2M9.0M7.8M
Total Non-Current Liabilities i802.3M844.7M717.8M757.8M739.3M
Total Liabilities i1.2B1.2B1.2B1.3B1.3B
Equity
Common Stock i21.4M21.4M21.4M19.5M19.4M
Retained Earnings i-23.4M25.8M23.5M7.8M
Treasury Stock i14.7M14.6M---
Other Equity-----
Total Shareholders Equity i323.6M308.5M298.8M223.0M195.9M
Key Metrics
Total Debt i875.2M886.7M911.5M1.0B971.5M
Working Capital i-38.2M-20.2M-177.8M-194.5M-255.9M

Balance Sheet Composition

Lna Santé S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i22.9M24.2M28.3M24.0M8.4M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-23.8M-38.9M-18.1M-43.4M56.9M
Operating Cash Flow i22.6M11.0M19.9M-2.7M82.4M
Investing Activities
Capital Expenditures i-10.5M-11.5M-10.9M-10.4M-9.0M
Acquisitions i-13.8M-3.2M-29.8M-15.9M-192.6M
Investment Purchases i-512.0K-287.0K-259.0K-814.0K-1.2M
Investment Sales i405.0K415.0K329.0K2.9M1.5M
Investing Cash Flow i-24.4M-14.6M-40.6M-24.2M-201.3M
Financing Activities
Share Repurchases i0-6.5M-4.4M-522.0K-4.3M
Dividends Paid i-6.1M-5.1M-4.5M-1.9M-4.3M
Debt Issuance i54.6M59.6M152.5M297.0M253.9M
Debt Repayment i-48.5M-69.8M-226.9M-243.2M-134.8M
Financing Cash Flow i-28.6M-48.6M-54.2M34.3M92.5M
Free Cash Flow i98.3M84.6M89.9M66.0M132.7M
Net Change in Cash i-30.4M-52.2M-74.9M7.4M-26.4M

Cash Flow Trend

Lna Santé S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 13.10
Forward P/E 10.18
Price to Book 0.91
Price to Sales 0.36
PEG Ratio 10.18

Profitability Ratios

Profit Margin 2.71%
Operating Margin 8.43%
Return on Equity 7.25%
Return on Assets 2.80%

Financial Health

Current Ratio 0.91
Debt to Equity 270.87
Beta 0.64

Per Share Data

EPS (TTM) €2.13
Book Value per Share €30.69
Revenue per Share €78.89

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
lna286.3M13.100.917.25%2.71%270.87
Emeis S.A 2.1B0.021.20-23.02%-7.31%514.45
Orpea 2.0B0.100.85704.66%26.07%485.11
Clariene SE 1.6B9.760.43-1.54%-1.16%209.58
Ramsay Générale de 1.1B34.130.99-5.16%-1.55%337.92
EssilorLuxottica 118.0B48.883.076.44%8.74%36.58

Financial data is updated regularly. All figures are in the company's reporting currency.